0 items USD 0.00Search
Your search for "globaldata systemic lupus erythematosus global clinical trials review h2 2018" gave back 128 results.
The global liquid biopsy market is predicted to surpass US$ 11 Billion by 2030. The advantages of liquid biopsy over solid tumor biopsy, rising...
Catalog:
iGATE
June 2022
Price: USD 3,490.00
Asia Pacific DNA sequencing market will grow by 17.4% annually with a total addressable market cap of $ 75,903.7 million over 2022-2031, driven by...
Grace Market Data
March 2022
Price: USD 2,880.00
Europe DNA sequencing market was valued at $ 3,287.4 million in 2021 and will grow by 15.2% annually over 2021-2031, driven by the significant...
Grace Market Data
March 2022
Price: USD 2,880.00
North America DNA sequencing market is projected to grow by 14.8% annually in the forecast period and reach $20,330.9 million by 2031, driven by the...
Grace Market Data
March 2022
Price: USD 2,880.00
RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation,...
Catalog:
La Merie Publishing
November 2022
Price: USD 2,500.00
Competitor Analysis: Bispecific Antibodies for Immuno-Oncology & Other Diseases This Competitive Intelligence report about Bispecific Antibodies...
Catalog:
La Merie Publishing
June 2019
Price: USD 900.00
Global DNA sequencing market will reach $52,278.1 million by 2031, growing by 15.4% annually over 2021-2031, driven by the significant technological...
Grace Market Data
March 2022
Price: USD 3,480.00
Cadherins are a family of glycoproteins responsible for calcium ion–dependent cell adhesion. There are more than 100 types of cadherins in humans,...
Catalog:
La Merie Publishing
May 2022
Price: USD 450.00
This report provides a landscape description and analysis of chimeric antigen receptor-macrophage (CAR-M) platform technologies and stakeholders from...
Catalog:
La Merie Publishing
February 2023
Price: USD 2,000.00
Biosimilars are copied versions of biologics that offer a 20-50% reduction in cost compared with innovative biologic products. Biosimilars are...
Catalog:
CBR Pharma Insights
June 2015
Price: USD 2,995.00
This report describes and evaluates the competitive landscape of CD22-targeted immunotherapeutics based on different treatment modalities. In B-cell...
Catalog:
La Merie Publishing
November 2016
Price: USD 784.00
This Competitive Intelligence report about Activators of Immune Checkpoints CD40, GITR, OX40, 4-1BB, CD27 & ICOS provides a competitor evaluation...
Catalog:
La Merie Publishing
November 2016
Price: USD 560.00
The report “Antibody Technologies and Attrition Rates – an industry analysis 2013” is based on the identification of the antibody generation...
Catalog:
La Merie Publishing
March 2013
Price: USD 2,960.00
The global ophthalmic devices market is predicted to reach US$ 68.2 Billion by 2027. Ophthalmic devices are medical devices used in the...
Catalog:
iGATE
February 2022
Price: USD 2,190.00
Biosimilar and Biosuperior Therapeutic Antibodies 2014 The present Competitive Intelligence Report about Biosimilar and Biosuperior Therapeutic...
Catalog:
La Merie Publishing
March 2014
Price: USD 1,514.00
